Insider plans sale of 5,149 shares via Form 144

An affiliate of the issuer filed a Form 144 notice to sell 5,149 shares of common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $1,847,588.97.

Accepted by SEC EDGAR 02/10/2026 - 04:04 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

An affiliate of the issuer filed a Form 144 notice to sell 5,149 shares of common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $1,847,588.97. The filing notes 69,958,056 shares outstanding at the time of the notice.

The shares to be sold were acquired from the issuer through a mix of performance shares, restricted stock, and stock option exercise, including 4,424 shares obtained via a cash stock option exercise on 02/10/2026. Additional smaller lots were acquired on various dates in 2023 and 2024 as equity awards.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing mean for CPAY investors?

The Form 144 shows an affiliate of CPAY plans to sell 5,149 common shares on the NYSE, worth $1,847,588.97. It is a disclosure of a potential insider sale, not a confirmation that all shares have already been sold.

How many CPAY shares are covered by this planned Form 144 sale?

The notice covers a proposed sale of 5,149 shares of CPAY common stock. These shares have an aggregate market value of $1,847,588.97 based on the price reference used in the filing for the planned transaction.

How many CPAY shares are outstanding compared to this Form 144 sale?

The filing states there are 69,958,056 CPAY common shares outstanding. The planned sale of 5,149 shares represents a small fraction of that total, indicating this is a relatively modest transaction in relation to overall share count.

How were the CPAY shares in this Form 144 acquired?

The shares to be sold were acquired from the issuer via performance shares, restricted stock, and stock option exercise. One line item shows 4,424 shares obtained through a cash stock option exercise on 02/10/2026, with smaller lots from prior equity awards.

Which broker is handling the planned CPAY share sale in this Form 144?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker. The address is given as 1 New York Plaza, 8th Floor, New York, NY 10004, and the sale is planned for execution on the NYSE.

When is the CPAY insider planning to sell these shares under Form 144?

The notice indicates an approximate sale date of 02/10/2026 for the 5,149 CPAY common shares. This is an intended timing disclosure and does not guarantee that all shares will be sold on that exact date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001824163
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CORPAY, INC.
SEC File Number	001-35004
Address of Issuer	3280 Peachtree Road, Suite 2400 Atlanta GEORGIA 30305
Phone	(770) 449-0479
Name of Person for Whose Account the Securities are To Be Sold	ALISSA VICKERY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5149	1847588.97	69958056	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/24/2024	Performance Shares	Issuer			90	01/24/2024	Not Applicable
Common	02/10/2026	Stock Option Exercise	Issuer			4424	02/10/2026	Cash
Common	04/10/2023	Performance Shares	Issuer			2	04/10/2023	Not Applicable
Common	03/01/2024	Restricted Stock	Issuer			159	03/01/2024	Not Applicable
Common	04/22/2023	Restricted Stock	Issuer			70	04/22/2023	Not Applicable
Common	03/01/2024	Performance Shares	Issuer			404	03/01/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Alissa Blaire Vickery
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)